In silico and in vitro evaluation of a PE38 and Nb‐based recombinant immunotoxin targeting the GRP78 receptor in cancer cells

Documenti analoghi

• Evaluation of suppressor behavior of guanidine‐derived metformin and galegine as novel potential drugs for cancer treatment: an in silico study
  di: Mohammad Behrouzi Varjovi, et al.
  Pubblicazione: (2024)
• A novel multi‐epitope peptide vaccine targeting immunogenic antigens of Ebola and monkeypox viruses with potential of immune responses provocation in silico
  di: Shirin Mahmoodi, et al.
  Pubblicazione: (2024)
• Inhibitory effects of Gracilaria edulis and Gracilaria salicornia against the MGMT and VEGFA biomarkers involved in the onset and advancement of glioblastoma using in silico and in vitro approaches
  di: Miji Thandaserry Vasudevan, et al.
  Pubblicazione: (2024)
• Design of casein‐based nanocarriers for targeted delivery of daunorubicin to leukemia cells
  di: Ali Beigrezaei, et al.
  Pubblicazione: (2024)
• Combination MEG3 lncRNA and Ciprofloxacin dramatically decreases cell migration and viability as well as induces apoptosis in GC cells in vitro
  di: Dena Najafi, et al.
  Pubblicazione: (2024)